Regis Healthcare Stock

Regis Healthcare P/S

The (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. of Regis Healthcare (REG.AX) as of Jul 30, 2026 is 1.61. In the previous year, (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. was 1.85 — a change of -12.68% (lower).

P/S

1.61

YoY

-12.68%

Last updated:

As of Jul 30, 2026, Regis Healthcare's P/S ratio stood at 1.61, a -12.68% change from the 1.85 P/S ratio recorded in the previous year.

The Regis Healthcare P/S history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/S
Date
P/S
Jan 1, 2019
1.14 base
Jan 1, 2020
0.76 base
Jan 1, 2021
0.75 base
Jan 1, 2022
0.72 base
Jan 1, 2023
1.25 base
Jan 1, 2024
1.78 base
Jan 1, 2025
1.82 base
Jan 1, 2026 (e)
1.36 base
YEARP/S
2026 est 1.36
2025 1.82
2024 1.78
2023 1.25
2022 0.72
2021 0.75
2020 0.76
2019 1.14
2018 1.34
2017 1.87
2016 2.86
2015 3.63
2014 2.78
2013 -
2012 -
Access this data via the Eulerpool API

Regis Healthcare Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Regis Healthcare's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Regis Healthcare's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Regis Healthcare's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Regis Healthcare grows earnings faster than its peers.

Regis Healthcare Stock analysis

What does Regis Healthcare do? Regis Healthcare Ltd is an Australian company that was founded in 1994. It has become one of the leading providers of aged care services in Australia and currently operates over 55 care facilities throughout the country. Regis Healthcare's business model can be described as "full-service" as the company offers a wide range of aged care services to its customers. These include accommodation and care in care facilities, as well as other services such as home care, day care, and palliative care. Regis Healthcare maintains a variety of facilities tailored to the needs of older people with different care requirements. These include facilities for assisted living, 24-hour care, and facilities for people with dementia. A major focus of Regis Healthcare is the quality of its services. The company takes a holistic approach to care and its staff is trained to provide optimal care to the customers. This includes actively involving family members and relatives in the care process. Regis Healthcare's offerings include not only comprehensive aged care services but also special programs such as "It Takes Two" for couples who want to live together in a care facility. Regis Healthcare also offers specialized programs for people with dementia and Parkinson's disease. Another important aspect of Regis Healthcare is its role as an employer. The company employs over 7,000 staff, including nurses, care assistants, cleaners, and administrative personnel. Regis Healthcare places great emphasis on qualified staff and offers its employees a range of professional development opportunities. Regis Healthcare has experienced steady growth in recent years and plans to continue expanding in the future. The company aims to expand its range of aged care services and increase its presence in regions with high demand for care facilities. Overall, Regis Healthcare is a leading provider of aged care services in Australia. The company offers a wide range of care facilities and services tailored to the individual needs and care requirements of its customers. Regis Healthcare prioritizes quality, holistic care, and active involvement of family members in the care process. Regis Healthcare is one of the most popular companies on Eulerpool.

P/S Details

Decoding Regis Healthcare's P/S Ratio

Regis Healthcare's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Regis Healthcare's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Regis Healthcare's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Regis Healthcare’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Regis Healthcare stock

(Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. of Regis Healthcare is 1.61 in 2026.

The P/S ratio when valuing a stock.

The price-to-sales ratio (P/S ratio) is an important tool of technical analysis that assists investors in evaluating stocks. It refers to the earnings per share of a company and its price movements. This indicator can be used to determine a stock's fair value, relative to the company's earnings.

History of the Price-to-Sales Ratio

The price-to-sales ratio is a relatively new indicator. It was first used in the 1980s by John Price when he developed the Price-to-Sales Index (PSI). Price wanted to find a way to value stocks taking into account their earnings. He noticed that many stock prices were not in line with their earnings situation. The PSI has since become an important analytical tool and is often referred to as the P/S ratio.

Calculation of the price-to-sales ratio

The price-to-sales ratio is easy to calculate. It is determined by dividing the current stock price by the company's earnings per share. P/S ratio = Stock price / Earnings per share. For example, if a company's stock price is $10 and the earnings per share is $2, then the P/S ratio is 5.

Application of the Price-to-Sales Ratio

The Price-to-Sales ratio is a useful tool for determining a fairly valued stock price. A low P/S ratio may indicate that a stock price is undervalued, which could be a good entry opportunity. However, a high Price-to-Sales ratio may indicate that a stock price is overvalued and investors should exercise caution.

An example: A company has a stock price of 20 USD and an earnings per share of 2 USD. The P/E ratio is 10. This could indicate that the stock price is overvalued and investors should be cautious before buying.

Investors and the price-to-sales ratio

Investors use the price-to-sales ratio to determine whether a company's stock price is fairly valued or not. They can compare the P/S ratio to see how the stock price relates to the company's earnings. Investors can also observe the P/S ratio over a longer period of time to see if the stock price changes in relation to the company's earnings.

Advantages and Disadvantages of the Price-to-Sales Ratio

The greatest advantage of the price-to-sales ratio is that it is a simple and understandable tool to determine the fair value of a stock price. It can also help investors identify stocks that are undervalued. One disadvantage is that the P/S ratio does not provide information about the company's profits. Therefore, investors should also consider other financial ratios before investing.

In today's time, the price-to-sales ratio is an important tool for investors to evaluate stocks and identify potential investment opportunities. It can help find a fairly valued stock price and identify stocks that are undervalued. However, investors should also consider other financial indicators before making an investment decision.

Access this data via the Eulerpool API

Valuation — Regis Healthcare

All Key Metrics — Regis Healthcare